(Q51808103)

12 April 2018

title

Prognostic value of interleukin-6 during a 3-year follow-up in patients with acute ST-segment elevation myocardial infarction. (English)

1 reference

12 April 2018

main subject

myocardial infarction

1 reference

Jing Tan

1

1 reference

12 April 2018

Qi Hua

series ordinal

2

1 reference

12 April 2018

Jing Li

series ordinal

3

1 reference

12 April 2018

Zhenxing Fan

series ordinal

4

1 reference

12 April 2018

publication date

27 September 2009

1 reference

12 April 2018

published in

Heart and Vessels

1 reference

12 April 2018

volume

24

1 reference

12 April 2018

issue

5

1 reference

12 April 2018

page(s)

329-334

1 reference

12 April 2018

https://scigraph.springernature.com/pub.10.1007/s00380-008-1128-8

exact match

0 references

cites work

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00380-008-1128-8

Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.

21 January 2018

1 reference

12 December 2020

Nicorandil suppresses the increases in plasma level of matrix metalloproteinase activity and attenuates left ventricular remodeling in patients with acute myocardial infarction

1 reference

12 December 2020

Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy

1 reference

12 December 2020

C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris

1 reference

12 December 2020

Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome

1 reference

12 December 2020

Soluble CD40 Ligand in Acute Coronary Syndromes

1 reference

12 December 2020

Soluble CD40L: risk prediction after acute coronary syndromes

1 reference

12 December 2020

Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction.

1 reference

12 December 2020

Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction.

1 reference

12 December 2020

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction

1 reference

12 December 2020

Close association of regional interleukin-6 levels in the infarct-related culprit coronary artery with restenosis in acute myocardial infarction

1 reference

12 December 2020

Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction

1 reference

12 December 2020

Atherosclerosis — An Inflammatory Disease

1 reference

12 December 2020

Inflammation in atherosclerosis

1 reference

12 December 2020

Relation of circulating interleukin-6 to left ventricular remodeling in patients with reperfused anterior myocardial infarction.

1 reference

12 December 2020

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

1 reference

12 December 2020

The impact of hs C-reactive protein and other inflammatory biomarkers on long-term cardiovascular mortality in patients with acute coronary syndromes.

1 reference

12 December 2020

Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris

1 reference

12 December 2020

Inflammatory markers and coronary artery disease

1 reference

12 December 2020

Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease

1 reference

12 December 2020

The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes.

1 reference

12 December 2020

Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome

1 reference

12 December 2020

10.1007/S00380-008-1128-8

Identifiers

DOI

1 reference

12 April 2018

PubMed ID

19784814

1 reference

12 April 2018